Publications by Elin Ødegaard
10 publications found
Original articles
ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival
PLoS One, 7 (9), e46317
DOI 10.1371/journal.pone.0046317, PubMed 23029477
Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma
Hum Pathol, 41 (6), 794-804
DOI 10.1016/j.humpath.2009.09.017, PubMed 20153512
Assessment of endoglin and calprotectin as potential biomarkers in ovarian carcinoma and borderline tumors of the ovary
Am J Obstet Gynecol, 199 (5), 533.e1-8
DOI 10.1016/j.ajog.2008.04.004, PubMed 18533117
Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary
Am J Obstet Gynecol, 198 (4), 418.e1-7
DOI 10.1016/j.ajog.2007.10.792, PubMed 18241816
Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy
Acta Obstet Gynecol Scand, 86 (5), 620-6
DOI 10.1080/00016340701286934, PubMed 17464594
The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma
Hum Pathol, 38 (1), 140-6
DOI 10.1016/j.humpath.2006.06.027, PubMed 16996570
What characterizes successful it projects
Int. J. Inf. Technol. Decis. Mak., 4 (4), 525-540
DOI 10.1142/S0219622005001738
The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma
Gynecol Oncol, 100 (3), 462-8
DOI 10.1016/j.ygyno.2005.09.022, PubMed 16216317
[Intractable postpartum haemorrhage treated with selective arterial embolization]
Tidsskr Nor Laegeforen, 123 (19), 2715-6
PubMed 14600743
Theses
Ovarian carcinomas and borderline ovarian tumors: molecular markers and operative treatment
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 623, 1 b. (flere pag.)
BIBSYS 080696023, ISBN 978-82-8072-902-6